Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Overviews: 9 Aspects of this Diagnoses
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Possible Special Education
      • Possible Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • First Pages of Diagnoses from the Diagnostic and Statistical Manual and the Codes from the ICD-10 for Diagnosis and Compensation
  • Medical & Educational Downloads
  • Contact Us
Select Page

Networks and clusters of immunometabolic biomarkers and depression-associated features in middle-aged and older community-dwelling US adults with and without depression

by jlohrconsulting | Oct 17, 2025 | Uncategorized

Brain Behav Immun Health. 2025 Sep 17;49:101103. doi: 10.1016/j.bbih.2025.101103. eCollection 2025 Nov. ABSTRACT INTRODUCTION: Therapy-resistant depression is associated with higher levels of systemic inflammation and increased odds of metabolic disorders. It is,...

Reliability and validity of the Brief Attention and Mood Scale of 7 Items: a self-administered, online assessment

by jlohrconsulting | Oct 17, 2025 | Uncategorized

Front Psychol. 2025 Oct 1;16:1579235. doi: 10.3389/fpsyg.2025.1579235. eCollection 2025. ABSTRACT Changes in technology, regulatory guidance, and COVID-19 have spurred an explosion in online studies in the social and clinical sciences. This surge has led to a need for...

Pesticide Exposure and the Risk of Depression, Anxiety, and Suicide: A Meta-Analysis

by jlohrconsulting | Oct 17, 2025 | Uncategorized

West J Nurs Res. 2025 Oct 17:1939459251383089. doi: 10.1177/01939459251383089. Online ahead of print. ABSTRACT BACKGROUND: Psychological distress, including anxiety, depression, and suicidality, may be influenced by environmental exposures such as pesticides. However,...

What does taking olanzapine mean to young people with anorexia nervosa and their families? Findings from the OPEN feasibility trial

by jlohrconsulting | Oct 17, 2025 | Uncategorized

J Eat Disord. 2025 Oct 16;13(1):228. doi: 10.1186/s40337-025-01401-z. ABSTRACT BACKGROUND: Olanzapine is a second-generation antipsychotic medication often prescribed for young people with Anorexia Nervosa (AN), though supporting evidence is limited. The OPEN...

“This is my place of reference”: transition from adolescent to adult care in a qualitative study of patients with anorexia nervosa

by jlohrconsulting | Oct 17, 2025 | Uncategorized

J Eat Disord. 2025 Oct 16;13(1):226. doi: 10.1186/s40337-025-01397-6. ABSTRACT BACKGROUND: Anorexia nervosa (AN) is a polyfactorial, long-term condition with an important risk of chronicity, that mainly emerges in adolescence. The transition to adulthood care is a...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments